{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:17:07Z","timestamp":1791559027930,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07403-0","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:00:48Z","timestamp":1784264448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retinopathy of prematurity screening and treatment practice patterns: an African multi-country survey"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-355X","authenticated-orcid":false,"given":"Jonathan","family":"Malcolm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-6489","authenticated-orcid":false,"given":"David","family":"Ngabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-1712","authenticated-orcid":false,"given":"Elie","family":"Nziyomaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1200-3739","authenticated-orcid":false,"given":"Livin","family":"Uwemeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6120-4603","authenticated-orcid":false,"given":"Sylvain","family":"EL-Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9887-0992","authenticated-orcid":false,"given":"Youssef","family":"AbdelMassih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-5894","authenticated-orcid":false,"given":"Michael A.","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"7403_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2025.5103","author":"ES Wong","year":"2025","unstructured":"Wong ES, Choy RW, Zhang Y et al (2025) Global and Regional Trends in Retinopathy of Prematurity. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.5103","journal-title":"JAMA Ophthalmol"},{"key":"7403_CR2","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, Ramke J, Marques AP et al (2021) The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Global Health 9:e489\u2013e551. https:\/\/doi.org\/10.1016\/S2214-109X(20)30488-5","journal-title":"Lancet Global Health"},{"key":"7403_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/bjo-2022-321522","volume":"108","author":"S El-Khoury","year":"2024","unstructured":"El-Khoury S, Strittmatter S, Tuyisabe T et al (2024) Distribution and causes of blindness and severe visual impairment in children at a tertiary referral centre in Rwanda. Br J Ophthalmol 108:280\u2013284. https:\/\/doi.org\/10.1136\/bjo-2022-321522","journal-title":"Br J Ophthalmol"},{"key":"7403_CR4","doi-asserted-by":"publisher","first-page":"e057864","DOI":"10.1136\/bmjopen-2021-057864","volume":"12","author":"H Gyllensten","year":"2022","unstructured":"Gyllensten H, Humayun J, Sj\u00f6bom U et al (2022) Costs associated with retinopathy of prematurity: a systematic review and meta-analysis. BMJ Open 12:e057864. https:\/\/doi.org\/10.1136\/bmjopen-2021-057864","journal-title":"BMJ Open"},{"key":"7403_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/heapol\/czy004","volume":"33","author":"L Hariharan","year":"2018","unstructured":"Hariharan L, Gilbert CE, Quinn GE et al (2018) Reducing Blindness from Retinopathy of Prematurity (ROP) in Argentina Through Collaboration, Advocacy and Policy Implementation. Health Policy Plann 33:654\u2013665. https:\/\/doi.org\/10.1093\/heapol\/czy004","journal-title":"Health Policy Plann"},{"key":"7403_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jamaophthalmol.2025.5515","volume":"144","author":"T Rittiphairoj","year":"2026","unstructured":"Rittiphairoj T (2026) The Global Epidemiologic Transition of Retinopathy of Prematurity: Interpreting Forecasts Through a Health-System Lens. JAMA Ophthalmol 144:147. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.5515","journal-title":"JAMA Ophthalmol"},{"key":"7403_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/09286586.2019.1585885","volume":"26","author":"D Wang","year":"2019","unstructured":"Wang D, Duke R, Chan RP, Campbell JP (2019) Retinopathy of prematurity in Africa: a systematic review. Ophthalmic Epidemiol 26:223\u2013230. https:\/\/doi.org\/10.1080\/09286586.2019.1585885","journal-title":"Ophthalmic Epidemiol"},{"key":"7403_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0140-6736(97)01107-0","volume":"350","author":"C Gilbert","year":"1997","unstructured":"Gilbert C, Rahi J, Eckstein M et al (1997) Retinopathy of prematurity in middle-income countries. Lancet 350:12\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(97)01107-0","journal-title":"Lancet"},{"key":"7403_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/09286586.2021.1910315","volume":"29","author":"SK Herrod","year":"2022","unstructured":"Herrod SK, Adio A, Isenberg SJ, Lambert SR (2022) Blindness Secondary to Retinopathy of Prematurity in Sub-Saharan Africa. Ophthalmic Epidemiol 29:156\u2013163. https:\/\/doi.org\/10.1080\/09286586.2021.1910315","journal-title":"Ophthalmic Epidemiol"},{"key":"7403_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1053\/j.semperi.2019.05.002","volume":"43","author":"C Gilbert","year":"2019","unstructured":"Gilbert C, Malik ANJ, Nahar N et al (2019) Epidemiology of ROP update \u2013 Africa is the new frontier. Semin Perinatol 43:317\u2013322. https:\/\/doi.org\/10.1053\/j.semperi.2019.05.002","journal-title":"Semin Perinatol"},{"key":"7403_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12886-025-04572-0","volume":"25","author":"MF Ismail","year":"2025","unstructured":"Ismail MF, Khalafalla I, Sheck ZO et al (2025) Prevalence and associated factors of retinopathy of prematurity in sub\u2013Saharan Africa: a systematic review and meta\u2013analysis. BMC Ophthalmol 25:699. https:\/\/doi.org\/10.1186\/s12886-025-04572-0","journal-title":"BMC Ophthalmol"},{"key":"7403_CR12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","volume":"402","author":"EO Ohuma","year":"2023","unstructured":"Ohuma EO, Moller A-B, Bradley E et al (2023) National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet 402:1261\u20131271. https:\/\/doi.org\/10.1016\/S0140-6736(23)00878-4","journal-title":"Lancet"},{"key":"7403_CR13","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/s41372-021-01040-7","volume":"41","author":"SK Herrod","year":"2021","unstructured":"Herrod SK, Stevenson A, Vaucher YE et al (2021) Oxygen management among infants in neonatal units in sub-Saharan Africa: a cross-sectional survey. J Perinatol 41:2631\u20132638. https:\/\/doi.org\/10.1038\/s41372-021-01040-7","journal-title":"J Perinatol"},{"key":"7403_CR14","doi-asserted-by":"publisher","unstructured":"Lloyd T, Isenberg S, Lambert SR (2020) Current management of retinopathy of prematurity in sub-Saharan Africa. J Am Association Pediatr Ophthalmol Strabismus 24:151.e1-151.e6. https:\/\/doi.org\/10.1016\/j.jaapos.2020.03.002","DOI":"10.1016\/j.jaapos.2020.03.002"},{"key":"7403_CR15","unstructured":"The Royal College of Ophthalmologists (2022) Treating Retinopathy of Prematurity in the UK. https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2022\/03\/Treating-Retinopathy-of-Prematurity-in-the-UK.pdf Accessed 22 March 2026"},{"key":"7403_CR16","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.oret.2025.03.020","volume":"9","author":"Y Abdelmassih","year":"2025","unstructured":"Abdelmassih Y, el-Khoury S, Mikhail M (2025) Fluorescein Angiography for Retinopathy of Prematurity with High Oxygen Exposure in a Tertiary Referral Center in Rwanda. Ophthalmol Retina 9:e111. https:\/\/doi.org\/10.1016\/j.oret.2025.03.020","journal-title":"Ophthalmol Retina"},{"key":"7403_CR17","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaophthalmol.2016.1669","volume":"134","author":"EL Ross","year":"2016","unstructured":"Ross EL, Hutton DW, Stein JD et al (2016) Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. JAMA Ophthalmol 134:888. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.1669","journal-title":"JAMA Ophthalmol"},{"key":"7403_CR18","doi-asserted-by":"publisher","first-page":"e0197670","DOI":"10.1371\/journal.pone.0197670","volume":"13","author":"F Van Asten","year":"2018","unstructured":"Van Asten F, Michels CTJ, Hoyng CB et al (2018) The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration\u2014A cost-effectiveness analysis from a societal perspective. PLoS One 13:e0197670. https:\/\/doi.org\/10.1371\/journal.pone.0197670","journal-title":"PLoS ONE"},{"key":"7403_CR19","doi-asserted-by":"publisher","unstructured":"Lema\u00eetre D, Barjol A, Abdelmassih Y et al (2021) Treatment outside the Recommended Guidelines for Retinopathy of Prematurity (ROP): Prevalence, Characteristics, and Issues. JCM 11(39). https:\/\/doi.org\/10.3390\/jcm11010039","DOI":"10.3390\/jcm11010039"},{"key":"7403_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","volume":"124","author":"DK VanderVeen","year":"2017","unstructured":"VanderVeen DK, Melia M, Yang MB et al (2017) Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity. Ophthalmology 124:619\u2013633. https:\/\/doi.org\/10.1016\/j.ophtha.2016.12.025","journal-title":"Ophthalmology"},{"key":"7403_CR21","doi-asserted-by":"publisher","first-page":"a220","DOI":"10.4102\/jcmsa.v3i1.220","volume":"3","author":"N Bandi","year":"2025","unstructured":"Bandi N, Sutton C, Van Der Lecq T (2025) Audit of a retinopathy of prematurity screening programme in the Limpopo province, South Africa. J Colleges Med South Afr 3:a220. https:\/\/doi.org\/10.4102\/jcmsa.v3i1.220","journal-title":"J Colleges Med South Afr"},{"key":"7403_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/njo.njo_19_20","volume":"28","author":"N Kennedy","year":"2020","unstructured":"Kennedy N, Ademola-Popoola D (2020) Coverage and Challenges of Retinopathy of Prematurity Screening and Treatment in Nigeria: Perspectives of Ophthalmologists and Paediatricians. Niger J Ophthalmol 28:61. https:\/\/doi.org\/10.4103\/njo.njo_19_20","journal-title":"Niger J Ophthalmol"},{"key":"7403_CR23","doi-asserted-by":"publisher","unstructured":"Van Der Lecq T, Holmstr\u00f6m G, Jordaan E et al (2026) Variations in prevalence of retinopathy of prematurity (ROP) and completeness of screening in five units within a South African region: a register-based study. Eye. https:\/\/doi.org\/10.1038\/s41433-026-04257-y","DOI":"10.1038\/s41433-026-04257-y"},{"key":"7403_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/bjo-2025-327597","volume":"110","author":"D Kumawat","year":"2026","unstructured":"Kumawat D, Kandasamy S, Chandra P (2026) Reactivation of retinopathy of prematurity after anti-VEGF treatment: a review. Br J Ophthalmol 110:117\u2013124. https:\/\/doi.org\/10.1136\/bjo-2025-327597","journal-title":"Br J Ophthalmol"},{"key":"7403_CR25","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.ophtha.2015.04.023","volume":"122","author":"MA Klufas","year":"2015","unstructured":"Klufas MA, Patel SN, Ryan MC et al (2015) Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity. Ophthalmology 122:1601\u20131608. https:\/\/doi.org\/10.1016\/j.ophtha.2015.04.023","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07403-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:00:49Z","timestamp":1784264449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07403-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":25,"alternative-id":["7403"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07403-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved an anonymous survey of healthcare professionals and did not include patient data. According to local regulations, formal ethical approval was not required. Participation was voluntary, and informed consent was obtained electronically prior to survey completion.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study prior to survey completion.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}